Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review

Objectives: The aim of this study was to describe our experience of a combination treatment including meropenem/vaborbactam (M/V) plus aztreonam (ATM) for bloodstream infections (BSIs) due to ceftazidime/avibactam-resistant Klebsiella pneumoniae (CAZ/AVI-R-Kp), for which gene typing was not availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Belati, Alessandra, Bavaro, Davide Fiore, Diella, Lucia, De Gennaro, Nicolò, Di Gennaro, Francesco, Saracino, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944480/
https://www.ncbi.nlm.nih.gov/pubmed/35326836
http://dx.doi.org/10.3390/antibiotics11030373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944480/
https://www.ncbi.nlm.nih.gov/pubmed/35326836
http://dx.doi.org/10.3390/antibiotics11030373

Ejemplares similares